Vanderbilt identifies genes linked to breast cancer chemo resistance
by Dagny Stuart | Posted on Monday, Jun. 11, 2012 — 3:15 PM
A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
Contact:
Dagny Stuart, (615) 936-7245
Dagny.stuart@vanderbilt.edu
Share This Story
Explore Story Topics
External Story, Health and Medicine, Reporter, Research 
American Association for Cancer Research, American Cancer Society, biomarker, breast cancer, Breast Cancer Research Foundation, cancer, Carlos Arteaga, chemotherapy, DNA, featured research, genes, Genetic Medicine, genetics, Justin Balko, Lee Jeans Translational Breast Cancer Research Program, NCI, NIH, personalized medicine, pharmacology, SPORE, Stand Up To Cancer, vicc
Related Stories
-
Breast cancer study explores therapy to slow recurrenceMarch 21, 2013 -
Vanderbilt study finds diverse genetic alterations in triple-negative breast cancersDecember 7, 2012 -
More gene links to breast cancer riskOctober 19, 2012 -
Vanderbilt University Medical Center observes Breast Reconstruction Awareness (BRA) DayOctober 16, 2012
Latest Research News
- Copyright Act needs updating, Vanderbilt law professor testifies before CongressMay 16, 2013
- World’s smallest dropletsMay 16, 2013
- National Geographic: The mystery of riskMay 16, 2013
- Study finds disagreement on the role of primary care nurse practitionersMay 16, 2013
- Most math being taught in kindergarten is old news to studentsMay 16, 2013
Find Us On: